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Abstract 
Background and objective: Type 2 diabetes mellitus (T2DM) complications 
seriously affect the quality of life and could not be cured completely. Actions should be 
taken for prevention and self-management. Analysis of warning factors is beneficial for 
patients, on which some previous studies focused. They generally used the professional 
medical test factors or complete factors to predict and prevent, but it was inconvenient 
and impractical for patients to self-manage. With this in mind, this study built a 
Bayesian network (BN) model, from the perspective of diabetic patients’ self-
management and prevention, to predict six complications of T2DM using the selected 
warning factors which patients could have access from medical examination. 
Furthermore, the model was analyzed to explore the relationships between 
physiological variables and T2DM complications, as well as the complications 
themselves. The model aims to help patients with T2DM self-manage and prevent 
themselves from complications. 
Methods: The dataset was collected from a well-known data center called the 
National Health Clinical Center between 1st January 2009 and 31st December 2009.  
After preprocess and impute the data, a BN model merging expert knowledge was built 
with Bootstrap and Tabu search algorithm. Markov Blanket (MB) was used to select 
the warning factors and predict T2DM complications. Moreover, a Bayesian network 
without prior information (BN-wopi) model learned using 10-fold cross-validation both 
in structure and in parameters was added to compare with other classifiers learned using 
10-fold cross-validation fairly. The warning factors were selected according the 
structure learned in each fold and were used to predict. Finally, the performance of two 
BN models using warning features were compared with Naïve Bayes model, Random 
Forest model, and C5.0 Decision Tree model, which used all features to predict. Besides, 
the validation parameters of the proposed model were also compared with those in 
existing studies using some other variables in clinical data or biomedical data to predict 
T2DM complications. 
Results: Experimental results indicated that the BN models using warning factors 
performed statistically better than their counterparts using all other variables in 
predicting T2DM complications. In addition, the proposed BN model were effective 
and significant in predicting diabetic nephropathy (DN) (AUC: 0.831), diabetic foot 
(DF) (AUC: 0.905), diabetic macrovascular complications (DMV) (AUC: 0.753) and 
diabetic ketoacidosis (DK) (AUC: 0.877) with the selected warning factors compared 
with other experiments. 
Conclusions: The warning factors of DN, DF, DMV, and DK selected by MB in 
this research might be able to help predict certain T2DM complications effectively, and 
the proposed BN model might be used as a general tool for prevention, monitoring, and 
self-management. 
Keywords：Bayesian network, Type 2 Diabetes Mellitus complications, prevention, 
self-management, warning factors 
1. Introduction 
Diabetes Mellitus (DM) is associated with various metabolic disorders, heavily 
enlarging the charge of non-communicable diseases [1], and chronic hyperglycemia due 
to insufficient insulin action is the main feature [2]. Type 2 diabetes mellitus (T2DM) 
accounts for 85% to 90% of all diabetic cases, which imposes the burden on not only 
individuals but the healthcare system [1,3]. Moreover, T2DM leads to complications 
such as kidney failure, blindness, cardiovascular diseases, nerve damage, ketoacidosis 
and foot problems, which seriously affect the quality of life, cause significant economic 
burdens to family and society, and even result in death [4-9]. The number of people 
with T2DM complications has been increasing, especially for young populations, which 
yearly increases the socio-economic societal burden of them [10]. According to a 
research carried out by Chapman et al. [11], the microvascular complications contribute 
extensively to the economic burden, and with the condition has been being more serious, 
the overall cost was exceeding £  70 million over the two years. Therefore, the 
prevention of T2DM complications is significant for hospitals and patients with 
diabetes. 
There are two methods of preventing complications that continuous medical care 
and long-term self-management. T2DM could not be cured completely but be 
controlled by medication, diet, and lifestyle changes [12-13]. In other words, the long-
term prevention of complications is necessary for the patients with T2DM. However, 
nowadays, healthcare resources are limited and costly, especially in the impoverished 
area [14-15]. It is impractical to rely entirely on the medical care in the hospital. 
Moreover, doctors are more likely to advise patients to do diabetic self-care at home if 
the symptom is not severe. Consequently, actions should be taken for prevention and 
self-management. 
Warning factors are strong contributors to certain outcome variables, which could 
be used widely to predict and support decision making in medical informatics [16-17]. 
For patients, warning factors could prevent them from the presence of a particular 
disease. In other words, analysis for warning factors plays a vital role in disease 
prevention. Machine Learning has been developing rapidly in recent years, and 
simulation models built with it are increasingly applied to derive predictions and 
analyze the warning factors of T2DM complications. Cho et al. [18] compared the 
prediction results of diabetic nephropathy between several classification methods with 
39 features and showed the effect of each feature on the decision using the visualization 
tool. A fuzzy classification model was employed to predict heart and kidney 
complications with six attributes of clinical data [19]. Leung et al. [20] using 10 clinical 
attributes and 5 genetic attributes built different models with seven machine learning 
methods to predict warning patterns in diabetic kidney disease. There are also some 
studies suggesting the biomedical factors such as endostatin [21-22], microRNAs 
(miRNAs) [23] and red blood cell deformability index [24] to predict T2DM 
complications or predict the T2DM development in certain patients. 
It is essential for diabetic patients to self-manage and to improve self-care skills 
with known warning features so that they can prevent themselves from complications 
to avoid severe conditions [25]. Therefore, the selection of the features from datasets is 
significant. It is inconvenient and unpractical for patients to obtain the features referring 
to professional medical test indicators and to input all features to the models that not 
dealing with the incomplete data sets when they take actions to self-manage and make 
prevention. However, there are few studies analyzing warning factors of T2DM 
complications from the perspective of diabetic patients’ self-management and 
prevention, and most of them only focus on one complication. 
Bayesian networks (BNs) representing the conditional probability between random 
variables graphically is an increasingly popular method that deals with uncertain and 
complex fields. They are more capable of dealing with incomplete data sets with better 
performance than many other models and revealing the causal relationships between 
variables [26-27]. Our paper mainly aims to build a Bayesian network (BN) model to 
find out and analyze the warning factors of T2DM complications with Markov blanket 
(MB) and use them to predict complications of T2DM. The warning features consist of 
urine test data, glycated hemoglobin (HbA1c) and biochemical parameters, which 
patients could have access from medical examination. We analyze the model to explore 
the relationships between physiological variables and T2DM complications, as well as 
the complications themselves. The model could probably be beneficial for prevention, 
monitoring and self-management, and that might be more convenient and manageable 
for patients. Besides, the model is probably capable of applying in different scenarios 
based on hypothetical cases when new observations are instantiated according to the 
patients’ situation. 
This paper is organized as follows. Section 2 explains the collected data used in 
this study and its processing methods, displays the flow of building a BN model, and 
analyzes the final T2DM complications model and the warning features selection. 
Section 3 adds a Bayesian network without prior information model (BN-wopi), and 
describes the comparison results with the other three models used in the diagnosis and 
presents the effectiveness of the previous studies’ prediction to demonstrate the 
performance of warning factors of the BN model in prediction further. Section 4 
discusses the warning factors of T2DM complications using MB and several specific 
scenarios. We conclude the study and suggest our future topics and applications in the 
last section. 
2. Materials and Methods 
In this section, we will demonstrate some concepts of methods we used in the study 
and the learning flow of our BN model in detail. First, we will describe the data 
collected and the approaches of preprocessing and imputation. Then, we will introduce 
BNs and MB, and some related basic concepts of connection and separation in BNs. 
After that, the process of building a T2DM complication model will be presented, and 
the structural and parametric learning approaches of the model will be described in 
detail. We will describe the final T2DM complications model and analyze the warning 
features of complications with MB in the last section. 
Our models are developed in RStudio, with mice, vice, bnlearn and ROCR 
packages mainly. The BNs model is operated in Netica to analyze the warning features 
of T2DM complications. 
2.1 Data Collection 
Based on data from a well-known data center called the National Health Clinical 
Center, we learned the structure and the probability distributions of our BN model. All 
inpatient sample databases related complications of diabetes were provided by the 
General Hospital of the People's Liberation Army (PLAGH), and they were extracted 
for the period 1st January 2009 to 31st December 2009. The original data collected 
particularly from the Hospital Information System (HIS) were followed the principle 
of authenticity and professional characteristic that is recording the accurate and 
unprocessed value of each test and real information about the inpatients. Each case was 
taken down after diagnosis during hospitalization. It could be classified into three 
categories according to the property of data: basic information, physiological 
information, and complications information. Specifically, physiological information 
consists of urine test variables, HbA1C test variables and biochemical test variables. 
In this data set, there are 43 features in all. To protect the privacy of patients, we 
removed the ID column. Moreover, we also removed lipase (LPS), ferrum (Fe) and 
unsaturated iron-binding capacity (TIBC) variables because of the large portion of 
missing values. Therefore, the dataset we used in this study to build the model and 
assess the warning feature contains 39 features including age and gender, 13 items 
related to the urine test, glycated hemoglobin (HbA1c) and 23 items related to the 
biochemical test. There are six complications variables, which are diabetic nephropathy 
(DN), diabetic retinopathy (DR), diabetic foot (DF), diabetic macrovascular 
complications (DMV), diabetic peripheral neuropathy (DPN), and diabetic ketoacidosis 
(DK) in this study. 
Considering the readability, the convenience of training model using these data, 
and the influence of outlier on the result, we integrated the information of each patient 
into one case and then removed the value of the same variable that was contradictory 
during one stay in the hospital, which leads to the independence between the cases. The 
contradictory value here means that the ones of discretized variables, and there are three 
situation (for one patient in one stay in the hospital): (i) if there are less 30% values of 
the variable in other states, whereas other values are in the certain state, the value of the 
variable is regarded as in this state. If there are more than 30% of values are abnormal 
values, we are concerned about them; (ii) If the abnormal values are in the same state, 
such as Low or High, the value of the variable is regarded as in this state; (iii) if the 
abnormal values are in a different state, the value of the variable is regarded as a missing 
value. As a result, the total number of data used in the model is 1485 and the records 
with complications are 755. 
2.2 Data Preprocessing and Imputation 
We decided to rely on discrete state BNs. Thus each continuous variable has to be 
discretized. According to the criterion of age provided by the World Health 
Organization and the age distribution in the dataset, we set three cut-offs of it. For 
variables present nominally, we indexed them with the discrete values directly. In 
addition, for variables with normal range values, we set two or three discrete values of 
normal and high or low normal and high. The details and the abbreviations of variables 
are listed in Table 1. 





Age Numeric / [20-55, 56-69,≥70]   0.00% 
Gender Nominal / [male, female] 0.00% 
Urine Leucocyte (U-LEU) Nominal 0-36/ul  [normal, high] 0.20% 
Specific Gravity (SG) Nominal neg [normal, low, high] 0.27% 
Urobilinogen (URO) Nominal neg [neg, pos] 0.20% 
Urine Bilirubin (U-BIL) Nominal neg [neg, pos] 0.20% 
Red Blood Cell (RBC) Numeric 0-27/ul [normal, high] 0.20% 
Yeast-Like Cells (YLC) Numeric 0-0/ul  [normal, high] 0.27% 
Glucosuria (U-GLU) Numeric 0-0mg/dl [normal, high] 0.20% 
Crystaluria (CRY) Numeric 0 [normal, high] 0.34% 
Urine PH value (PH) Numeric 4.5-7.9 [normal, high] 0.20% 
Urine Color (COL) Nominal 
yellow、
light 
[normal, dark, other] 8.35% 
Griess Test (NIT) Nominal neg [neg, pos] 0.20% 




Urine Ketone (U-KET) Nominal neg [normal, high] 0.20% 
Glycated Hemoglobin 
(HbA1C) 
Numeric 4.1-6.5% [normal, low, high] 36.50% 
Alanine Aminotransferase 
(ALT) 
Numeric 0-40U/L [normal, high] 2.09% 
Aspartate 
Aminotransferase (AST) 
Numeric 0-40U/L [normal, high] 2.15% 
Total Protein (TP) Numeric 55-80g/L [normal, low, high] 8.82% 
Serum Albumin (ALB) Numeric 35-50g/L [normal, low, high] 5.05% 
Total Bilirubin (TB) Numeric 0-21umol/L [normal, low, high] 10.24% 
Direct Bilirubin (DBIL) Numeric 0-8.6umol/L [normal, high] 10.91% 
Alkaline Phosphatase 
(ALP) 
Numeric 0-130U/L [normal, high] 15.42% 
Urea (UREA) Numeric 
1.8-
7.5mmol/L 
[normal, low, high] 2.36% 
γ Glutamyl Transferase 
(GGT) 
Numeric 0-50U/L [normal, high, higher] 14.14% 
Creatinine (Cr) Numeric 
30-
110umol/L 
[normal, low, high] 2.36% 
Glucose (GLU) Numeric 
3.4-
6.1mmol/L 
[normal, low, high] 5.25% 
Triglycerides (TRIG) Numeric 
0.4-
1.7mmol/L 
[normal, high, chyle] 22.96% 
Uric Acid (UA) Numeric 
104-
444mmol/L 
[normal, low, high] 8.35% 
Total Cholesterol (TC) Numeric 
3.1-
5.7mmol/L 
[normal, low, high] 22.56% 
Creatine Kinase (CK) Numeric 2-200U/L 






[normal, low, high,  
hemolysis] 
18.86% 
Calcium (Ca) Numeric 
2.09-
2.54mmol/L 
[normal, low, high] 12.46% 
Sodium (Na) Numeric 
130-
150mmol/L 
[normal, low, high] 4.65% 
Potassium (K) Numeric 
3.5-
5.5mmol/L 
[normal, low, high] 3.97% 
Chloride (CL) Numeric 
94-
110mmol/L 
[normal, low, high] 6.33% 
Inorganic Phosphorus (IP) Numeric 
0.89-
1.6mmol/L 
[normal, low, high] 20.13% 
Magnesium (Mg) Numeric 
0.6-
1.4mmol/L 






[normal, low, high] 35.42% 
There are three types of missing data prevalent in statistics literature [28], (a) 
Missing Completely at Random (MCAR), (b) Missing at Random (MAR) and (c) 
Missing Not at Random (MNAR). The probability of missing data classified as 
"MCAR" is independent of observed values and missing data. The probability of 
missing data classified as "MAR" does not depend on the missing values but the 
observed data of other features, while the probability of missing data classified as 
"MNAR" depends on both of them. In our dataset, we could regard all of the missing 
data as "MCAR" and "MAR" under the assumption that something like the staff in 
hospital deleted values on purpose or patients refused to do the tests would not happen. 
It means that we could use some imputation methods to process the missing data. 
Multiple imputations are proved to be preferable rather than removing data entirely 
in some areas [29]. It is used in some literature for preprocessing missing values where 
the method called predictive mean matching usually presents the best performance 
when there are fewer than 50 percent cases including missing values [30-33]. Observing 
some missing values in the dataset, we used the VIM package embedded in RStudio to 
evaluate the distribution of missing values (refer to Figure 1). The red line takes up a 
part of the area, meaning that most of the missing values are about HbA1C and High-
Density Lipoprotein (HDL), which, however, take up fewer than 50 percent cases 
reported in Table 1 specifically. 
 
Figure 1: Distribution of missing values. 
Consequently, we did multiple imputations with predictive mean matching (PMM) 
for missing data [34-35]. Using the MICE package embedded in RStudio, we set the 
number of iterations to 50 to reduce the impact of random factors. The density of 
difference between before and after imputation is shown in Figure 2. It is worth noting 
that a good fitting effect is reported, so the dataset after processing could be used for 
model training. 
 
Figure 2: Density plot. 
For the discrete and orderly value of all variables, data are analyzed using Kendall 
rank correlation coefficient. As clear showed in Figure 3, the correlation between 
multiple variables reveals nearly linear independence, whereas the linear correlation 
shows between others. The Bayesian network is a method that can deal with the 
complex correlation between the variables and indicate more information about data. 
Therefore, we build the T2DM complication model based on it. 
 
Figure 3: Maps of the correlation coefficients of variables. 
The dataset was split into ten subsets of approximately equal size using 10-fold 
cross-validation [36], namely nine subsets used for training and the rest one subset for 
testing in turn for ten times. It aims to prevent the BNs model from overfitting through 
learning the model with the training sets and using the test to measure its performance. 
In our study, we used all data with the bootstrap approach (refer to Section 2.4.1) to 
learn the structure of BNs and used the training set with 10-fold cross-validation to do 
the parameters learning of BNs, calculating the mean values as the learning results. Ten 
times of probability prediction will be presented through some validation parameters as 
the final validation, with the purpose of a robust and effective model. 
2.3 Bayesian Networks and Markov Blanket 
Bayesian networks (BNs) is annotated directed graphs that represent a set of 
variables as nodes in a network, connected by edges representing the conditional 
probabilistic relations between them. A pair (𝐺, 𝑇) , where G represents a directed 
acyclic graph (DAG) and T is the set of parameters quantifying the network, specifies 
a Bayesian network (BN) [37-38]. A Bayesian network B always defines a joint 
probability distribution that could be factorized as a result of several conditional 
distributions over a set of random variables [39-40]: 
𝑃𝐵(𝑋1, ⋯ , 𝑋𝑛) = ∏ 𝑃𝐵(𝑋𝑖|𝜋𝑋𝑖) = ∏ 𝜃(𝑋𝑖|𝜋𝑋𝑖)






Note that ∏ 𝑋𝑖 denotes the parent nodes of the random variable 𝑋𝑖 and 𝜃 represents 
the conditional probability. It suggests that any node given the value of its parent nodes 
is conditionally independent of other all nodes that are not its descendants. This is 
known as Markov property [41]. The Markov blanket (MB) is the smallest subset of 
Bayesian network instantiating the property that all variables outside the MB could be 
deleted without influence on the target node and thus will have no impact on the 
accuracy of classification. It could be displayed as the following equation [42]: 
𝑃(𝑇|𝑌, 𝑀𝐵(𝑇)) = 𝑃(𝑇|𝑀𝐵(𝑇)) ∝ 𝑃(𝜋𝑇)𝑃(𝑇|𝜋𝑇)𝑃(𝐷𝑇|𝑇)𝑃(𝐷𝑇|𝜋𝐷𝑇 , 𝑇)𝑃(𝜋𝐷𝑇)(2)  
𝑀𝐵(𝑇) is the Markov blanket of target node T. 𝜋𝑇 represents the set of parent nodes 
of T whose child nodes are illustrated as 𝐷𝑇, and thus 𝜋𝐷𝑇 describes the other parent 
nodes of 𝐷𝑇 except the node T. Hence, MB is usually used in the feature selection [43-
44]. There are three types of connections and d-separation in MB. One of the 
connections is called serial (X →  Z →  Y or X ←  Z ←  Y), known as the 
intermediate cause where Z makes X and Y independent. The diverging connection is 
X← Z → Y, where X is independent with Y if Z is instantiated and vice versa. That is 
known as the common cause. If a trail is shown as X→ Z← Y and Z →R, it is regarded 
as a converging connection. It makes X and Y independent only if not knowing neither 
of Z and R, which means common effect. The independence between X and Y reported 
above could be called that X and Y are d-separated. It could be concluded that if X and 
Y are d-separated by Z, X and Y are conditionally independent given by Z. Therefore, it 
is apparent that any node in the BN is d-separated of the nodes included in the non-
Markov blanket given its Markov blanket. 
2.4 Learning Bayesian Networks 
There are two necessary steps to obtain a BN model: (i) structural learning to find 
the global optimum global structure proved as an NP problem, and (ii) parametric 
learning to estimate the conditional probability among nodes given a DAG. The entire 
process of building a T2DM complication model based on BN is presented in Figure 4. 
 
Figure 4: The implementation flow of the T2DM model. 
2.4.1 Structural Learning 
BNs learns the real probability distribution by updating the posterior distributions 
according to the observed evidence, based on prior knowledge. Therefore, we focus on 
combining data-driven evidence with prior knowledge derived from previous research 
when learning the BN structure. 
Sharma et al. [45] reported that total cholesterol (TC) and high-density lipoprotein 
(HDL) are related to cardiovascular diseases. According to Doliba et al. [46], Na+ 
levels may associate with the pathology of diabetic cardiomyopathy. Consequently, we 
assume that HDL, TC, and Na are related to DMV. Furthermore, Yang et al. [47] 
explored that NaV1.3 and NaV1.7, which are encoded by the Sodium (Na), contribute 
to the cause-effect relation between diabetes and painful neuropathy. Fadini et al. 
suggested that lower TRIG may protect kidney function from lip toxicity [48]. In other 
words, Na also seems to play an important role in the development of DPN and TRIG 
probably has an impact on DN. 
Based on the prior knowledge mentioned above, we created a whitelist, which is 
summarized in Table 2. It presents the forced edges on outcome nodes in our structure. 
In addition, age and gender are the variables not determined by the model. More in 
general, the state of the two factors does not depend on the rest of the model. Therefore, 
we put the edges from two nodes to other nodes into a blacklist. The whitelist and the 
blacklist are integrated into the structure learning of BN classifier, which we will 
present in the following details. 
Table 2: Forced edges on outcome nodes. 
Outcome Nodes Forced Parent Node 
DN TRIG 
DF / 




Two options could be chosen if several candidates' models can be accessed. One 
option is the most effective model, and the other is the average model that average over 
the other models. The final structure of our model was obtained with the approach 
called bootstrap by repeating 500 times structure learning, namely 500 BNs were 
learned. Each network was explored with a Tabu Search algorithm (tabu) [49] 
according to the likelihood-equivalence Bayesian Dirichlet score with uniform priors 
(BDeu), merging the whitelist listed above and the blacklist where age and gender 
variables were never the parent nodes. We set the length of the Tabu list to 100 and the 
Tabu search iterations to 15 [50]. To ensure the robustness of the model, the network 
learned the averaged the arc strength of 500 models calculated by the conditional 
probability of two connected nodes. Consequently, arcs, whose strengths are above 0.8, 
remained in the final structure given a threshold valued 80% (refer to Figure 5). 
 
Figure 5: The network of T2DM complications model. 
2.4.2 Parametric Learning 
Parameters are the probabilities distribution of all variables. As mentioned above, 
10-fold cross-validation was used to split the dataset into the training sets and test sets 
in parameter learning and make the estimation of the model accuracy. We can see the 
process of parametric learning in Figure 4. With ten subsets of approximately equal size 
divided in the beginning, the process repeated 10 times. There were nine subsets to train 
the model parameters with Maximum Likelihood Estimate (MLE) [51], and the rest 
subset was to validate the model performance with predicting probability using warning 
factors. After repeating for ten times, we calculate the average of conditional 
probabilities (θ) of every node as the result of parameter learning and there were 
validation sets consisted of each test set and their predicting probability.  
2.5 T2DM Complications Model and Warning Feature Analysis. 
To obtain a legible and unambiguous graphical representation from the structure 
and parameters of the T2DM complications model learned with bnlearn package in R 
language, we operated the BN in Netica (refer to Figure 6). As shown in Figure 6, the 
number of edges is high. Note that BNs structure learned by data-driven integrated with 
expert knowledge might have the ability to demonstrate more relationships between 
T2DM complications and physiological variables. 
 
Figure 6: T2DM complications model operated in Netica. 
As we can observe in Figure 6, the joint probability distribution of the BN model 
is factorized in 45 conditional probability tables (CPTs) where each table is for each 
node conditioned to the set of its parent nodes and presents the mean and standard 
deviation. It is worth noting that T2DM complications model seems to split the decision 
nodes and require two separate sub-networks to represent the original data distribution. 
Out of six T2DM complications, DR has no relationship with urine test items, HbA1c 
and biochemical test items. In other words, urine test, HbA1c and biochemical test 
could not be able to predict DR, which would be explored in other features to examine 
the warning factors.  
As for the other five complications, DK and DN variables are the child nodes of 
DMV variable, which is known as a common cause, and the connection between DK 
variable and DN variable is broken if DMV variable is initiated. Moreover, DMV 
variable is connected to DPN variable and DF variable through Na and HDL 
respectively. 
 The Market blanket of a variable consists of the set of its parent nodes, child nodes 
and the parent nodes of its child nodes as previously mentioned. The MB of DN variable 
is Age, TRIG, Cr and DMV variables, all of which are its parent nodes. That means the 
connection to DN variable via common cause trial and intermediate cause trial is broken 
if the MB is given. For DF and DPN variables, only the variables called HDL and Na 
are their MB respectively, which broke the trail to DMV variable. There are 10 variables 
including Age, TRIG, TC, Na, HDL that are parent nodes while DK and DN are child 
nodes. U-GLU, U-KET, Cr make the Markov blanket of DMV variables. As for DK 
variable, U-GLU, U-KET and DMV variables compose the MB. Table 3 summarizes 
the MB of five T2DM complications clearly. 
Table 3: The Markov blanket of T2DM complications variables. 
Complications Variables Markov Blanket Size of MB 
DN Age, TRIG, Cr, DMV 4 
DF HDL  1 
DMV 
Age, TRIG, TC, Na, 
HDL, DK, DN,U-GLU, 
U-KET, Cr 
10 
DPN Na 1 
DK U-GLU, U-KET, DMV 3 
3. Results 
To ensure the effectiveness and robustness of our T2DM complication model, we 
have two kinds of performance comparison in this section. The first part refers to the 
different baseline models including the Naïve Bayes model (NB) [52], Random Forest 
model (RF) [53], the C5.0 Decision Tree model (C5.0) [54]. We compare the 
performance from the perspective of several parameters with Area Under Curve (AUC) 
[55], 95% Confidence interval (95% CI), sensitivity and specificity. Following the 
formula described in (3) and (4), we could calculate sensitivity, which is also known as 
the true positive rate, and specificity which is known as true negative rate. Then we 
compare our validation parameters, especially AUC, with those in existing studies using 
some other variables in clinical data or biomedical data predicting T2DM complications 









                    (4) 
3.1 Performance Comparison between Models 
After the model learning, we validated the performance of prediction of the BN 
model using warning factors, and compared it with the NB, RF, and C5.0, which were 
used in the prediction of diseases with 10-fold cross-validation. In order to make a 
comparison with other classifiers fair, a Bayesian network without prior information 
(BN-wopi) model was studied, where both structural learning and parametric learning 
were performed using 10-fold cross-validation. The warning factors were selected 
according to the structure learned in each fold and were used to predict. The parameters 
of RF were set as follows: the number of variables randomly sampled as candidates at 
each split is set to three, and there are 100 trees allowed to grow. In relation to C5.0, 
the number of iteration was set to five. Note that warning factors were used to predict 
each outcome variable in the BN model and BN-wopi model, whereas all variables 
except the outcome variable were applied in classification tasks in NB, RF, and C5.0. 
Because of dataset distribution and the number of positive cases and negative cases, 
it is not reasonable to take the threshold as 0.5 then calculate the confusion matrix or 
error ratio. However, AUC is a preferable method to validate the effect of models [56] 
that takes the different predicted probabilities as the threshold and calculates the 
sensitivity and specificity respectively. Then there will be a Receiver Operating 
Characteristic Curve (ROC) and the area under it is the AUC. 
We added the prediction probability and test data of each fold of different models 
to four lists in two columns respectively. Accomplished with each iteration, the 
prediction probability column in training datasets was taken as the threshold one by one, 
except the same value, to calculate the sensitivity, specificity and AUC, which were 
used together with 95% CI to illustrate the predictive effect of models in the last. Figure 
7 describes the AUC, sensitivity and specificity indices of five models predicting the 
five complication variables each fold. In general, the two BN models outperformed 
other models in AUC and sensitivity. 
  
Figure 7: Fold by fold comparison in AUC, sensitivity and specificity. From top to 
bottom and left to right, the complications are DN, DF, DMV, DPN and DK orderly. 
The analysis of variance (ANOVA) test indicated that at least two models for the 
all evaluated indices are statistically significantly different (p < 0.05) with 10 folds. 
Then, the p-values of the paired test regarding the AUC are summarized in Table 4. The 
statistical analysis indicated that two BN models performed statistically better than or 
similar to their counterparts. By comparing BN model and BN-wopi model, though 
there is a statistically significant difference in predicting some of the complications, 
they show basically equally powerful prediction. 
In addition, as shown by the paired test results in Table 5, the sensitivity of two BN 
models are better than the other three models generally, whereas both BN models 
performed statistically similarly. In relation to specificity, other models statistically 
outperformed the BN models. However, note that their sensitivity reached a lower rate, 
which is undesirable for T2DM complications prediction using waring factors 
especially for self-management of patients. On the other hand, BN-wopi performed 
statistically better than or similar to BN model in the specificity of most of the 
complications except DPN complications. 
Table 4 : The p-values of the paired test for the AUC in the prediction of five 
complications (DN and DMV are in the upper triangular part, DF, DPN and DK are in 
the lower triangular part). The symbols in parentheses denote: (=) not statistically 
different; (+) statistically different, where the row is superior to the column; and (−) 
statistically different, where the row is inferior to the column. 
DF\DN BN BN-wopi NB RF C5.0 
BN - 0.46(=) 0.00(+) 0.14(=) 0.00(+) 
BN-wopi 0.27(=) - 0.14(=) 0.67(=) 0.00(+) 
NB 0.00(-) 0.00(-) - 0.46(=) 0.67(=) 
RF 0.00(-) 0.00(-) 0.01(=) - 0.09(=) 
C5.0 0.22(=) 0.76(=) 0.00(+) 0.00(+) - 
      
DPN\DMV BN BN-wopi NB RF C5.0 
BN - 0.00(+) 0.00(+) 0.00(+) 0.00(+) 
BNs-wopi 0.00(+) - 1.00(=) 1.00(=) 1.00(=) 
NB 1.00(=) 0.00(-) - 1.00(=) 1.00(=) 
RF 0.92(=) 0.00(-) 0.91(=) - 1.00(=) 
C5.0 1.00(=) 0.00(-) 1.00(=) 1.00(=) - 
      
DK BN BNs-wopi NB RF C5.0 
BN - - - - - 
BNs-wopi 0.19(=) - - - - 
NB 0.19(=) 0.01(=) - - - 
RF 0.00(-) 0.00(-) 0.09(=) - - 
C5.0 0.00(-) 0.00(-) 0.00(-) 0.00(-) - 
Table 6 lists detailed comparison result and Figure 8 shows the AUC of four models 
predicting the five complication variables. In relation to the different performance 
between the two BN models, BN-wopi outperformed the BN model with prior 
information in the variables of DPN and DK. It is most likely because the expert 
knowledge was not reflected in the dataset consisting of a limit number of cases so that 
the fitting between data and structure of the model is not very well in the BN model. 
Moreover, the performance in sensitivity and specificity between the two BN models is 
opposite in the variables of DN and DF. The BN model performed better in sensitivity, 
whereas BN-wopi performed better in specificity. The values of sensitivity and 
specificity of a model depend on the point which is the closest to (1,1) in order to 
maximize both of them on the coordinate plane (refer to Figure 8). To some extent, they 
are inverse. Due to the different structures, it is possible for two BN models that 
performed differently in sensitivity and specificity, which has little impact on the result 
of the comparison. Out of the four models learned using 10-fold cross-validation totally, 
it is clear that the BN-wopi model performs the best. When the confidence level is 
identical, narrower confidence intervention leads to the higher significance the AUC is. 
For the variables of DN, DPN and DK, the 95%CI of BN-wopi model is the narrowest, 
and for DMV variable, BN-wopi model performs the second best. Therefore, the AUC 
could represent the effectiveness of models to some extent, which means BN models 
using warning factors could give the best classification performances out of the other 
three models. 
Table 5: The p-values of the paired test for the sensitivity (upper triangular part) and 
specificity (lower triangular part) indices. The symbols in parentheses denote: (=) not 
statistically different; (+) statistically different, where the row is superior to the column; 
and (−) statistically different, where the row is inferior to the column. 
DN BN BN-wopi NB RF C5.0 
BN - 0.00(+) 0.00(+) 0.00(+) 0.00(+) 
BN-wopi 0.00(+) - 0.01(=) 0.00(-) 0.00(-) 
NB 0.00(+) 0.00(-) - 0.10(=) 0.00(-) 
RF 0.00(+) 0.70(=) 0.12(=) - 0.07(=) 
C5.0 0.00(+) 0.00(-) 0.70(=) 0.06(=) - 
      
DF BN BN-wopi NB RF C5.0 
BN - 0.10(=) 1.00(=) 0.00(+) 1.00(=) 
BN-wopi 0.79(=) - 0.10(=) 0.07(=) 0.10(=) 
NB 0.00(-) 0.00(-) - 0.00(+) 1.00(=) 
RF 0.00(-) 0.00(-) 0.00(+) - 0.00(-) 
C5.0 0.00(-) 0.00(-) 0.00(+) 0.11(=) - 
      
DMV BN BN-wopi NB RF C5.0 
BN - 1.00(=) 1.00(=) 1.00(=) 1.00(=) 
BN-wopi 0.00(+) - 1.00(=) 1.00(=) 1.00(=) 
NB 0.00(-) 1.00(=) - 1.00(=) 1.00(=) 
RF 0.00(+) 1.00(=) 1.00(=) - 1.00(=) 
C5.0 0.00(+) 1.00(=) 1.00(=) 1.00(=) - 
 
     
DPN BN BN-wopi NB RF C5.0 
BN - 0.85(=) 0.00(+) 0.00(+) 0.00(+) 
BN-wopi 0.00(-) - 0.00(+) 0.00(+) 0.00(+) 
NB 0.00(+) 0.00(+) - 0.00(+) 0.85(=) 
RF 0.00(+) 0.00(+) 0.00(+) - 0.00(-) 
C5.0 0.00(+) 0.05(=) 0.00(-) 0.00(-) - 
 
     
DK BN BN-wopi NB RF C5.0 
BN - 1.00(=) 0.00(+) 0.00(+) 0.00(+) 
BN-wopi 1.00(=) - 0.00(+) 0.00(+) 0.00(+) 
NB 0.00(+) 0.00(+) - 1.00(=) 1.00(=) 
RF 0.00(+) 0.00(+) 1.00(=) - 1.00(=) 
C5.0 0.00(+) 0.00(+) 1.00(=) 1.00(=) - 
Table 6: Performance of different models. The value only in bold performs the best in 
the row out of the last four models. The value in bold and italic performs the best in the 
row out of all models and is from the BN model. 
  Parameters\Models BN BN-wopi NB RF C5.0 












 Sensitivity 0.86 0.511 0.727 0.694 0.756 
  Specificity 0.655 0.959 0.788 0.906 0.826 
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  Specificity 0.891 0.884 0.541 0.604 0.602 












 Sensitivity 0.827 0.855 0.861 0.765 0.804 
  Specificity 0.563 0.584 0.503 0.633 0.599 












 Sensitivity 0.75 0.875 0.5 0.2 0.5 
  Specificity 0.475 0.457 0.827 1 0.554 












 Sensitivity 0.867 0.875 0.688 0.619 0.606 
  Specificity 0.76 0.817 0.917 0.968 0.912 
Consequently, our T2DM complications model with the Bayesian network 
classifies the condition of patient T2DM complications with the best performance using 
fewer variables. Furthermore, their graphical representation is very informative. 
  
Figure 8: AUC of four models in five complication variables. 
3.2 Performance Comparison with Other Experiments 
In order to demonstrate the performance of the BN model further in prediction and 
the ability of complications warning using features selected by MB methods, we 
summarize the performance of other experiments conducted previously in predicting 
T2DM complications.  
There are some related studies in Table 7 and most of them validate the 
performance with AUC of about 80%. For DK variables in five studies, more features 
demonstrate better effectiveness rather than one feature which needs to be examined 
through the professional test. However, more feature means more resources are needed. 
In our model, there are four features that are available in medical examination to predict 
DK. Although the AUC in different models or studies does not have comparability of 
suggesting a better model, the AUC of 0.831 [95%CI: 0.7947-0.8665] is capable of 
proving that our model performs well in predicting DK. Moreover, the prediction of DF 
in our T2DM complications model are confirmed to be well with AUC of 0.905 [95%CI: 
0.8841-0.9268], sensitivity of 1.0, and specificity of 0.891, while Irene et al. explored 
two methods with AUC of 0.776 [95% CI: 0.702–0.849], sensitivity of 0.83, specificity 
of 0.50, and AUC of 0.816 [95% CI: 0.757–0.874], sensitivity of 1.0, specificity of 0.32, 
respectively. Our model has a higher AUC of DMV prediction than AUC in existing 
related studies that is 0.75 on average. In other words, prediction in DMV also performs 
effectively with sensitivity of 0.827, higher than other related studies’ listed in Table 7. 
However, the AUC of 0.545 in prediction in DPN means that the Na variable does not 
predict DPN very well, whereas Lin et al revealed that serum uric acid demonstrates 
stronger predictive power to DPN. Few studies predict DK with clinical data or 
biomedical factors. Nevertheless, AUC of 0.877 [95% CI: 0.8182-0.9362] could be 
seen as a well-formed model in general. Figure 9 shows the comparison of AUC of 
different related studies. Warmer color in the spectrum means a higher number of 
features. 
Therefore, our model is proven to be effective in predicting DN, DF, DMV and DK 
based on the dataset. It might be beneficial in the prevention and self-management of 
diabetic patients in daily life. 
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Figure 9: Comparison with AUC of different studies. 
4. Discussion 
Following the results explored above, the BN model in this study is beneficial and 
useful to aid diabetic patients in preventing from four kinds of complications and to 
make self-care with just a few features that could be obtained in general medical 
examination. Moreover, we could instantiate some variables in the MB of every 
complication variable to attain more information about them. 
First, we focus on the DN variable. It is worth noting that the people aged between 
20 and 55 are more likely to have the DN complications with the probability of 18.5%, 
whereas the probability is under 14% in the other age categories. In addition, if the Cr 
variable has an abnormal value, the probability for DN will increase from 13.9% to 
above 40% (refer to Figure 10). When the TRIG variable is instantiated to Chyle, Figure 
10 shows the highest probability of DN variable of 41.8%. Besides the impact of feature 
variables, DMV variable is also associated with DN variable. When the DMV is in 
positive state, there is a probability of 4.4% at having DN at the same time. 
Consequently, diabetic patients could pay more attention to Cr and TRIG, especially 
for young people aged between 20 and 55. 
Because the positive cases of DF are below 3% of the sample size, the probability 
of DF in positive state is only 0.59%. HDL is the only variable that needs to be paid 
attention to, which in high condition will lead to a rise to 3.43% in the probability of 
DF (refer to Figure 11). 
  
Figure 10: Part of the T2DM complications model focus on DN variable and its MB. 
 
Figure 11: Part of the T2DM complications model focus on DF variable and its MB. 
Note that for DMV, there is a probability of 39.8% in the positive state of DMV in 
the people aged over 70 years old, which is the group of the highest probability. 
Furthermore, if TC, Na, HDL variables are in High state and TRIG variable is in Chyle 
state respectively, there is always a rise in the probability of DMV. As we can see in 
Figure 12, the state of DN variable has no impact on DMV when the TC, Na, HDL 
variables are in High state, TRIG variable is in Chyle state, and Age variable is in the 
category of 56-69 state or over 70 whereas DK in the positive condition could have 
negative relationship with the DMV variable. In other words, it is just a little possibility 
for an elder to have DK and DMV at the same time when TC, Na, HDL, TRIG are all 
in a poor state. Diabetic patients who are in the condition would not focus on the DN 
and Cr variables. Then, both of U-GLU and U-KET variables could have a positive 
influence on DMV when DK is in negative condition. 
 
 
Figure 12: Part of the T2DM complications model focus on DMV variable and its MB. 
 For the DK variable, U-KET is the most important factor that the probability of DK 
increases from 3.24% to 11.6% when the state of U-KET is in positive. U-GLU also 
has a positive impact on DK variables (refer to Figure 13). 
 
Figure 13: Part of the T2DM complications model focus on DK variable and its MB. 
The data we used to build the model is from the inpatients who have already been 
diagnosed with various kinds of T2DM complications followed the principle of 
authenticity and professional characteristic, which means that the warning factors in 
BN model might be applied to self-monitoring of T2DM patients and the assistant 
treatment of T2DM complications. The model built in this paper aims to predict the 
condition of complications with warning features. Therefore, the analysis for warning 
factors of T2DM complications may be helpful to avoid or limit as much as possible 
two situations: (i) patients worried about T2DM complications may have access to 
ambulatory visit and health care services unnecessarily too often, and (ii) patients with 
no realization wait too long before they go to hospital and complications may occur. 
The one probable application scenario is that patients with T2DM use warning 
factors to predict the probability of T2DM complications. There is a certain threshold 
for each outcome variable in the model to distinguish the positive state and negative 
state, which means the highest accepted negative value. If the conditional probability 
of one of the complications is higher than the threshold when patients instantiate the 
warning factors, they are more likely to have had complications. It is advised for 
patients to see the doctor and do the relevant examination so that they could detect the 
complications or treat the disease as early as possible. 
In addition, it might be beneficial for diabetic patients to focus on the warning 
features and use warning features to monitor their physical condition related to 
complications before entering the hospital. If the warning features are at a normal level 
but close to the threshold value of the high or low, taking actions to control them around 
the average normal level might be beneficial. A diabetic patient, for example, finds that 
his HDL is 1.5mmol/L close to the threshold of high state. It might be good for him to 
do some exercise or have a more healthy diet to decrease the level of HDL which is 
related to DMV.  
Furthermore, the warning features could be obtained easily in medical 
examinations, which is convenient for diabetic patients to do self-management in daily 
life. 
5. Conclusions 
Analysis of warning factors of T2DM complications is necessary and significant. 
In this study, the warning factors of T2DM complications including urine test data, 
glycated hemoglobin (HbA1c) and biochemical test data with MB based on a BN model 
were found out and analyzed, and T2DM complications were predicted in a T2DM 
cohort. It was learned from the dataset related to complications of T2DM provided by 
PLAGH. According to the missing value, we did multiple imputations with PMM and 
split the dataset into the training set and testing set with 10-fold cross-validation. For 
different variables, we set two, three or four thresholds. 
Based on the prior knowledge, the structure of the BN model was built with 
Bootstrap and Tabu search algorithm merging data information and expert knowledge, 
which made a strong foundation of warning factors analysis. In addition, parameters of 
the model are learned with MLE and 10-fold cross-validation was used to learn 10 times. 
The MB is used to select the warning features. 
 We also compared the performance of BN model and BN without prior information 
model using warning factors with the Naïve Bayes model, the Random Forest model, 
and C5.0 Decision Trees model using all other variables in prediction from the 
perspective of AUC, 95%CI, sensitivity and specificity. Finally, the two BN models 
predicting the warning factors of outcome variables was proved the best. Then the 
comparison with other experiments was also carried out, the result of which indicated 
that the prediction in DN, DF, DMV and DK variables with warning factors was 
practically significant based on the dataset. Moreover, we made inferences of outcome 
variables with warning factors and reported the context of potential clinical assistant 
treatment of T2DM complications. 
Due to the limitation of sources and ways of collecting data, we could not get the 
further dataset on which we could make a prediction and perform the assessment. 
Besides, the method used in imputation which created correlations between samples 
leading to independent folds could be prompted. In terms of future directions, we intend 
to use more T2DM complication cases to test our model and train our model again and 
again to analyze warning factor more deeply, and improve our health management 
system in predicting tasks with these warning factors. The methods of processing 
missing data also needed to be explored further to make model building and assessment 
more reasonable. In addition, more features that are easy to be accessed to will be 
considered in our model to make predictions with warning features more convenient 
and reliable. 
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